CDx approval expands clinical utility of Oncomine Dx Target Test to identify candidates for TIBSOVO CARLSBAD, Calif. — The U.S. Food and Drug Administration (FDA) has granted pre-market approval to Thermo Fisher Scientific’s Oncomine Dx Target Test as a companion diagnostic (CDx) to identify patients with isocitrate dehydrogenase-1 (IDH1) mutated cholangiocarcinoma (CCA) who may be candidates for Servier Pharmaceuticals’ […]
IPSWICH, Mass. — New England Biolabs (NEB®) announces the release of its newest loop-mediated isothermal amplification (LAMP) products: the WarmStart Multi-Purpose LAMP/RT-LAMP 2X Master Mix (with UDG) and the WarmStart Fluorescent LAMP/RT-LAMP Kit (with UDG), which combines the master mix and LAMP fluorescent dye in one convenient kit. The new master mix and kit enable researchers to […]
Highly accurate HRD detection offers affordable and easily implementable solutions, opening new doors for healthcare São Paulo, Brazil and Boston, MA – Dasa, the largest integrated healthcare network in Brazil, has chosen to expand upon its partnership with SOPHiA GENETICS SA (Nasdaq: SOPH) to offer the first decentralized HRD (Homologous recombination deficiency) analytics solution in Latin […]
Milestone underlines company’s global leadership in sample preparation Company’s NGS assays also hit milestone of one million samples tested since 2015 New kits and instruments will bolster QIAGEN’s position in most crucial area of molecular testing GERMANTOWN, Md. & HILDEN, Germany– QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that the number of biological […]
The new approach will be tested in three cohorts of patients diagnosed with Cystic Fibrosis, Alzheimer’s Disease, and Coronary Artery Disease ATLANTA, GA, UNITED STATES — Sequegenics today announced that it has been awarded a National Science Foundation (NSF) Small Business Innovation Research (SBIR) grant for $251,073 to conduct research and development (R&D) work on a new approach […]
IPSWICH, Mass. — New England Biolabs (NEB) recently launched the NEBNext Immune Sequencing Kits, available for either human or mouse samples, to enable B-cell and/or T-cell repertoire (BCR and/or TCR) analysis of infections. The kits’ streamlined workflows and flexibility make them particularly useful for studies investigating the human immune response to infection and autoimmunity. Recently published examples […]
GRAIL will remain a separate and independent unit, pending ongoing regulatory and legal review SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) announced today that it has acquired GRAIL, a healthcare company focused on life-saving early detection of multiple cancers, but will hold GRAIL as a separate company during the European Commission’s ongoing regulatory review. Illumina, […]
BOULDER, Colo. & SOUTH SAN FRANCISCO, Calif. — CM Life Sciences II (Nasdaq: CMIIU) and SomaLogic, Inc., a leader in AI-data driven proteomics technology, and Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced a collaboration aimed at creating novel […]
BOSTON — Kerafast, Inc. announced today that King Abdullah University of Science and Technology (KAUST), located in Thuwal, Saudi Arabia, is the 200th academic institution to join their international community of scientists. Kerafast is the developer of an online portal for academic researchers worldwide to share their laboratory-created reagents. The company specializes in providing access to difficult-to-obtain materials, while […]
AMSBIO is a knowledgeable supplier of products dedicated to exosome research that includes high quality reagents and kits that are quick, affordable and easy to use. The latest addition to this portfolio is a new range of tools for isolating and purifying overall or specific exosome sub-populations from small volumes of sample in an efficient, […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
